Accelerating Australia’s RNA Innovation Pipeline – Southern RNA and UQ BASE

Southern RNA and The BASE Facility at The University of Queensland have established a collaborative framework that bridges academic research and clinical translation. Together, we provide a clear and efficient pathway for mRNA therapeutics & vaccines, from early construct design and optimisation to GMP-compliant
manufacturing, fully within Australia.

https://southernrna.com.au/wp-content/uploads/2025/10/UQ-Base-and-SRNA-1-566×800.png

A Seamless Translational Partnership

This collaboration enables researchers to:

• Optimise mRNA constructs at BASE, using processes aligned with Southern RNA’s industry standards.
• Transition efficiently into Southern RNA’s GMP manufacturing platform for clinical development.
• Reduce time and cost associated with technology transfer.
• Ensure continuity of quality, data, and documentation from R&D to clinical production.

See the PDF document here for the full article.